Agilent ACEA xCELLigence RTCA CardioECR Real-Time Cardiomyocyte Cell Analyzer System

The Agilent ACEA xCELLigence RTCA CardioECR System is a high-precision real-time cell analyzer designed for label-free monitoring of cardiomyocyte activity. The system integrates impedance measurement and field potential recording to assess cellular contractility, viability, and electrophysiology with high sensitivity and reproducibility. It is widely adopted in biotechnology research and molecular diagnostics for cardiac safety evaluation and drug discovery in biopharmaceutical production pipelines.

Key technical specifications include:

The system employs a non-invasive, label-free approach, preserving native cell behavior critical for live-cell imaging and cardiac electrophysiology studies. It supports both acute assays (seconds to minutes) and long-term assays (hours to days), facilitating in-depth analysis of cardiomyocyte function. This capability is essential in synthetic biology research, gene editing workflows, and bioprocessing environments where real-time cellular responses to pharmaceutical compounds are evaluated.

The system is delivered with:

Applications include:

This instrument is supported by thorough in-house servicing, calibration, and warranty coverage, reflecting the standards expected by clinical diagnostics laboratories and academic research facilities. The compact design and integrated software make it ideal for labs focused on biomanufacturing quality control and cardiac electrophysiology research fields.

Overall, the Agilent ACEA xCELLigence RTCA CardioECR system delivers robust, sensitive, and reproducible real-time cardiomyocyte analysis, making it critical in molecular biology laboratories and a popular choice among researchers in biomedical engineering and drug discovery domains focused on cardiac safety assessment.